Alemtuzumab-induced cytokine release syndrome: an under-appreciated risk in treatment of delayed renal allograft function.
| Autor: | D. J., Roberts1, A., Olyaei1,2, S., Rehman1, D. J., Norman1,3, A. M., de Mattos1, J. B., Lockridge1 lockridg@ohsu.edu |
|---|---|
| Zdroj: | Trends in Transplantation. 2020, Vol. 13 Issue 2, p1-3. 3p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|